221 related articles for article (PubMed ID: 29656267)
21. Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Δ
Boggs DL; Nguyen JD; Morgenson D; Taffe MA; Ranganathan M
Neuropsychopharmacology; 2018 Jan; 43(1):142-154. PubMed ID: 28875990
[TBL] [Abstract][Full Text] [Related]
22. THC and CBD in blood samples and seizures in Norway: Does CBD affect THC-induced impairment in apprehended subjects?
Havig SM; Høiseth G; Strand MC; Karinen RA; Brochmann GW; Strand DH; Bachs L; Vindenes V
Forensic Sci Int; 2017 Jul; 276():12-17. PubMed ID: 28463706
[TBL] [Abstract][Full Text] [Related]
23. 'Standard THC units': a proposal to standardize dose across all cannabis products and methods of administration.
Freeman TP; Lorenzetti V
Addiction; 2020 Jul; 115(7):1207-1216. PubMed ID: 31606008
[TBL] [Abstract][Full Text] [Related]
24. Predictors of perceived symptom change with acute cannabis use for mental health conditions in a naturalistic sample: A machine learning approach.
Kuhathasan N; Ballester PL; Minuzzi L; MacKillop J; Frey BN
Compr Psychiatry; 2023 Apr; 122():152377. PubMed ID: 36787672
[TBL] [Abstract][Full Text] [Related]
25. Acute and chronic effects of cannabidiol on Δ⁹-tetrahydrocannabinol (Δ⁹-THC)-induced disruption in stop signal task performance.
Jacobs DS; Kohut SJ; Jiang S; Nikas SP; Makriyannis A; Bergman J
Exp Clin Psychopharmacol; 2016 Oct; 24(5):320-330. PubMed ID: 27690502
[TBL] [Abstract][Full Text] [Related]
26. Examining the Use of Antidepressants for Adolescents with Depression/Anxiety Who Regularly Use Cannabis: A Narrative Review.
Hen-Shoval D; Weller A; Weizman A; Shoval G
Int J Environ Res Public Health; 2022 Jan; 19(1):. PubMed ID: 35010782
[TBL] [Abstract][Full Text] [Related]
27. Effects of marijuana extract distillate and cannabidiol on variable interval performance as a function of food deprivation.
Musty RE; Sands R
Pharmacology; 1978; 16(4):199-205. PubMed ID: 565058
[TBL] [Abstract][Full Text] [Related]
28. Daily associations with cannabis use and sleep quality in anxious cannabis users.
Bidwell LC; Sznitman SR; Martin-Willett R; Hitchcock LH
Behav Sleep Med; 2024 Mar; 22(2):150-167. PubMed ID: 37255232
[TBL] [Abstract][Full Text] [Related]
29. Motives Matter: Cannabis use motives moderate the associations between stress and negative affect.
Glodosky NC; Cuttler C
Addict Behav; 2020 Mar; 102():106188. PubMed ID: 31706141
[TBL] [Abstract][Full Text] [Related]
30. Effects of short-term cannabidiol treatment on response to social stress in subjects at clinical high risk of developing psychosis.
Appiah-Kusi E; Petros N; Wilson R; Colizzi M; Bossong MG; Valmaggia L; Mondelli V; McGuire P; Bhattacharyya S
Psychopharmacology (Berl); 2020 Apr; 237(4):1121-1130. PubMed ID: 31915861
[TBL] [Abstract][Full Text] [Related]
31. An investigation of cannabis use for insomnia in depression and anxiety in a naturalistic sample.
Kuhathasan N; Minuzzi L; MacKillop J; Frey BN
BMC Psychiatry; 2022 Apr; 22(1):303. PubMed ID: 35484520
[TBL] [Abstract][Full Text] [Related]
32. Acute Effects of Cannabis on Symptoms of Obsessive-Compulsive Disorder.
Mauzay D; LaFrance EM; Cuttler C
J Affect Disord; 2021 Jan; 279():158-163. PubMed ID: 33049434
[TBL] [Abstract][Full Text] [Related]
33. A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms.
Wade DT; Robson P; House H; Makela P; Aram J
Clin Rehabil; 2003 Feb; 17(1):21-9. PubMed ID: 12617376
[TBL] [Abstract][Full Text] [Related]
34. Beyond the CB1 Receptor: Is Cannabidiol the Answer for Disorders of Motivation?
Zlebnik NE; Cheer JF
Annu Rev Neurosci; 2016 Jul; 39():1-17. PubMed ID: 27023732
[TBL] [Abstract][Full Text] [Related]
35. Cannabis, cannabidiol, and epilepsy--from receptors to clinical response.
Szaflarski JP; Bebin EM
Epilepsy Behav; 2014 Dec; 41():277-82. PubMed ID: 25282526
[TBL] [Abstract][Full Text] [Related]
36. The effectiveness of inhaled Cannabis flower for the treatment of agitation/irritability, anxiety, and common stress.
Stith SS; Li X; Diviant JP; Brockelman FC; Keeling KS; Hall B; Vigil JM
J Cannabis Res; 2020 Dec; 2(1):47. PubMed ID: 33526145
[TBL] [Abstract][Full Text] [Related]
37. Δ9-Tetrahydrocannabinol alone and combined with cannabidiol mitigate fear memory through reconsolidation disruption.
Stern CA; Gazarini L; Vanvossen AC; Zuardi AW; Galve-Roperh I; Guimaraes FS; Takahashi RN; Bertoglio LJ
Eur Neuropsychopharmacol; 2015 Jun; 25(6):958-65. PubMed ID: 25799920
[TBL] [Abstract][Full Text] [Related]
38. Cross-sectional and prospective relation of cannabis potency, dosing and smoking behaviour with cannabis dependence: an ecological study.
van der Pol P; Liebregts N; Brunt T; van Amsterdam J; de Graaf R; Korf DJ; van den Brink W; van Laar M
Addiction; 2014 Jul; 109(7):1101-9. PubMed ID: 24628797
[TBL] [Abstract][Full Text] [Related]
39. Potency trends of Δ9-tetrahydrocannabinol, cannabidiol and cannabinol in cannabis in the Netherlands: 2005-15.
Niesink RJ; Rigter S; Koeter MW; Brunt TM
Addiction; 2015 Dec; 110(12):1941-50. PubMed ID: 26234170
[TBL] [Abstract][Full Text] [Related]
40. Short and Long-Term Effects of Cannabis on Symptoms of Post-Traumatic Stress Disorder.
LaFrance EM; Glodosky NC; Bonn-Miller M; Cuttler C
J Affect Disord; 2020 Sep; 274():298-304. PubMed ID: 32469819
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
